1. Safer Medicines Trust; Kingsbridge UK
2. Mechanistic Safety and Disposition; IVIVT; GlaxoSmithKline; Ware Hertfordshire UK
3. DILIsym Services Inc., a Simulations Plus Company; Research Triangle Park North Carolina USA
4. Drug Metabolism and Pharmacokinetics; Theravance Biopharma; South San Francisco California USA
5. Division of Pharmacotherapy and Experimental Therapeutics; UNC Eshelman School of Pharmacy; University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA
6. ADME-TOX; BioIVT; Durham North Carolina USA
7. Clinical Pharmacology; Research and Development Sciences; Agios Pharmaceuticals; Cambridge Massachusetts USA
8. Roche Pharmaceutical Research and Early Development; Pharmaceutical Sciences; Roche Innovation Center Basel; Basel Switzerland
9. Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism; Merck & Co., Inc; Kenilworth New Jersey USA
10. Drug Metabolism; Gilead Sciences Inc.; Foster City California USA
11. Safety Assessment; Genentech; South San Francisco California USA
12. Lilly Research Laboratory; Lilly Corporate Center; Eli Lilly and Company; Indianapolis Indiana USA
13. Department of Neurobiology, Care Sciences and Society; Karolinska Institute; Novum Huddinge Sweden
14. Mechanistic Safety and Drug Disposition; GlaxoSmithKline; King of Prussia Pennsylvania USA
15. PDM; Medicine Design; Pfizer Inc.; Groton Connecticut USA
16. Institute for Drug Safety Sciences; UNC Eshelman School of Pharmacy; University of North Carolina; Chapel Hill North Carolina USA
17. Takeda Pharmaceuticals, Global Drug Metabolism and Pharmacokinetics; Cambridge Massachusetts USA